NFKB1 and Menkes disease: Activation of the NF-κB pathway has been shown to downregulate SGK1 expression29; herein, the expression of NF-κB p65 was significantly upregulated in the VEO or primary VRML cells from patients with MD compared that in patients with AN (Supplementary Fig. 1e, f).